Accelerating Drug Discovery for FTD supports investigators developing small molecule and biologic drugs through lead optimization and animal-model testing to advance disease-modifying treatments for FTD.
Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.
The Treat FTD Fund from the Alzheimer's Drug Discovery Foundation supports early-stage research and clinical trials to develop new therapies and biomarkers for frontotemporal degeneration.
ADDF Diagnostics Accelerator Funding for FTD Biomarker Development supports researchers developing biomarkers for frontotemporal degeneration to advance diagnosis and treatment.
Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.
ADDF-Harrington supports academic investigators with research funding and drug development expertise to advance medicines for Alzheimer’s disease, related dementias, and aging-related cognitive decline.